FDA Risk Communication Advisory Cmte. Will Assess Pharmacy Leaflets’ Utility

FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs